H.R. 7895: PBM Kickback Prohibition Act
The PBM Kickback Prohibition Act is legislation aimed at addressing financial practices within the pharmacy benefit management (PBM) sector. The bill proposes an amendment to the Employee Retirement Income Security Act of 1974 that prohibits certain types of payments to individuals or firms in relation to pharmacy benefit management services.
Key Provisions of the Bill
- Prohibition of Kickbacks: The bill specifically prohibits pharmacy benefit managers from compensating brokerage firms, brokers, consultants, advisors, or any similar entities for referring business from health plans or health insurance issuers. This means that if a health plan contracts with a PBM for management services, the PBM cannot pay anyone to bring that business to them.
- Covered Plans and Providers: The provisions apply to contracts involving covered plans and covered service providers that offer pharmacy benefit management services. This is aimed at ensuring transparency and preventing unethical financial incentives that could influence the management of drug benefits.
- Implementation Timeline: The new regulations, if enacted, would take effect for plan years starting after the law is officially enacted. This means there is time for affected parties to adjust to the new rules once they are in place.
Purpose of the Bill
The bill aims to create a more fair and transparent marketplace by eliminating the potential for kickbacks that could lead to conflicts of interest in the management of pharmacy benefits. By ensuring that compensation structures for PBMs do not involve misleading or unethical practices, the legislation seeks to improve the integrity of health care pricing and services.
Impact on Health Care
By prohibiting kickbacks, the bill is intended to benefit health plan sponsors and ultimately consumers by potentially reducing costs associated with pharmacy benefits. It aims to prevent situations where financial incentives may unduly influence the choice of medications or pharmacy services to the detriment of patients and health plan members.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 12, 2026 | Introduced in House |
| Mar. 12, 2026 | Referred to the House Committee on Education and Workforce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.